News for Verona Pharma plc (VRNA)

Published at

Mar 5, 2025 2:20 PM

by insidermonkey.com

neutral

neutral

Verona Pharma plc (VRNA): A Bull Case Theory

We came across a bullish thesis on Verona Pharma plc (VRNA) on Value Investing Subreddit Page by loud_keyb. In this article, we will summarize the bulls’ thesis on VRNA.

VRNA

Read more →
Published at

Mar 1, 2025 5:03 AM

by gurufocus.com

positive

positive

PERCEPTIVE ADVISORS LLC Acquires Significant Stake in Outset Medical Inc

Significant Transaction by PERCEPTIVE ADVISORS LLC (Trades, Portfolio) On January 8, 2025, PERCEPTIVE ADVISORS LLC (Trades, Portfolio) executed a noteworthy tra

VRNA RYTM.MX RYTM OM FOLD.MX FOLD 0HF9.L

Read more →
Published at

Feb 28, 2025 8:18 AM

by gurufocus.com

positive

positive

Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid Financial Challenges

Net Sales of Ohtuvayre (Q4 2024): $36.6 millionNet Sales of Ohtuvayre (Full Year 2024): $42.3 millionCost of Ohtuvayre Sales (Q4 2024): $2 millionCost of Ohtuv

VRNA

Read more →
Published at

Feb 28, 2025 6:40 AM

by gurufocus.com

positive

positive

Decoding Verona Pharma PLC (VRNA): A Strategic SWOT Insight

Verona Pharma PLC's innovative respiratory therapeutics position it as a key player in a niche market.Financial prudence and strategic partnerships could prope

VRNA

Read more →
Published at

Feb 28, 2025 6:12 AM

by gurufocus.com

positive

positive

Q4 2024 Verona Pharma PLC Earnings Call Transcript

Feb 27, 2025 / 02:00PM GMTOperator Good morning ladies and gentlemen. Welcome to the Verona Pharma's fourth quarter and full year 2024 financial results and con

VRNA

Read more →
Published at

Feb 27, 2025 8:31 PM

by seekingalpha.com

positive

positive

Verona Pharma plc (VRNA) Q4 2024 Earnings Call Transcript

Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Conference Call February 27, 2024 9:00 AM ETCompany ParticipantsDavid Zaccardelli - President and CEOMark...

VRNA

Read more →
Published at

Feb 27, 2025 1:17 PM

by manilatimes.net

mixed

mixed

Ligand Reports Fourth Quarter and Full Year 2024 Financial Results

**media[552077]**

VRNA VKTX TVTX NOVN GILDD.BA GILD CASI AMGN AGEN LGND

Read more →
Published at

Feb 27, 2025 12:37 PM

by gurufocus.com

positive

positive

Verona Pharma PLC Q4 2024 Earnings: EPS of -$0.05 Beats Estimate, Revenue of $36.6M Surpasses Expectations

Revenue: Achieved net product sales of $36.6 million in Q4 2024, surpassing the estimated revenue of $33.05 million.Earnings Per Share (EPS): Reported a net lo

VRNA

Read more →
Published at

Feb 27, 2025 12:12 PM

by seekingalpha.com

neutral

neutral

Verona Pharma GAAP EPS of -$0.05 beats by $0.12, revenue of $35.65M beats by $2.21M (NASDAQ:VRNA)

Verona Pharma (VRNA) Q4 results: GAAP EPS of -$0.05 beats estimates by $0.12, revenue hits $35.65M, surpassing forecasts by $2.21M.

VRNA

Read more →
Published at

Feb 27, 2025 12:00 PM

by gurufocus.com

positive

positive

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in

VRNA

Read more →
Published at

Feb 26, 2025 1:15 PM

by gurufocus.com

positive

positive

Earnings To Watch: Verona Pharma PLC (VRNA) Reports Q4 2024 Result

Verona Pharma PLC (VRNA) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $0.03 billion, and the earnings a

VRNA

Read more →
Published at

Feb 23, 2025 9:08 PM

by insidermonkey.com

positive

positive

Verona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025?

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025.

VRNA

Read more →
Published at

Feb 23, 2025 12:54 PM

by gurufocus.com

positive

positive

PERCEPTIVE ADVISORS LLC Expands Stake in Edgewise Therapeutics Inc

Significant Acquisition by PERCEPTIVE ADVISORS LLC (Trades, Portfolio) On February 13, 2025, PERCEPTIVE ADVISORS LLC (Trades, Portfolio) made a notable addition

VRNA RYTM.MX RYTM FOLD.MX FOLD EWTX 0HF9.L

Read more →
Published at

Feb 23, 2025 12:51 PM

by gurufocus.com

mixed

mixed

Perceptive Advisors LLC Increases Stake in Solid Biosciences Inc

On February 19, 2025, Perceptive Advisors LLC made a significant move by acquiring an additional 5,028,033 shares of Solid Biosciences Inc (SLDB). This transact

SLDB VRNA RYTM.MX RYTM NUVL FOLD.MX FOLD 0HF9.L

Read more →
Published at

Feb 19, 2025 8:39 AM

by gurufocus.com

positive

positive

Verona Pharma PLC (VRNA) Announces Participation in Key Healthcare Conferences

Verona Pharma PLC (VRNA), a biopharmaceutical company specializing in innovative therapies for chronic respiratory diseases, announced on February 18, 2025, tha

VRNA

Read more →
Published at

Feb 15, 2025 5:24 PM

by gurufocus.com

positive

positive

RA Capital Management, L.P. Expands Stake in Verona Pharma PLC

On December 31, 2024, RA Capital Management, L.P. made a significant move by acquiring an additional 2,768,289 shares of Verona Pharma PLC. This transaction inc

VRNA RYTM.MX RYTM PCVX JANX

Read more →
Published at

Feb 13, 2025 12:00 PM

by gurufocus.com

positive

positive

Verona Pharma PLC (VRNA) Announces Upcoming Financial Results Release and Conference Call

Summary Verona Pharma PLC (VRNA), a biopharmaceutical company specializing in innovative therapies for chronic respiratory diseases, has announced that it will

VRNA

Read more →
Published at

Feb 13, 2025 12:00 PM

by gurufocus.com

positive

positive

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc ( VRNA) (”Verona Pharma” or the ”Company”) announces that it will report

VRNA

Read more →
Published at

Feb 13, 2025 3:08 AM

by gurufocus.com

positive

positive

Caligan Partners LP Acquires Significant Stake in Verrica Pharmaceuticals Inc

On December 31, 2024, Caligan Partners LP (Trades, Portfolio) made a strategic move by acquiring 15,856,653 shares of Verrica Pharmaceuticals Inc. This transact

VRNA VRCA EXEL EX9.DE EOLS ANIK 0K16.L 0IJO.L

Read more →
Published at

Feb 12, 2025 2:50 PM

by zacks.com

positive

positive

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'

If you are looking for stocks that are well positioned to maintain their recent uptrend, Verona Pharma (VRNA) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

VRNA

Read more →